Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,958 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Skin/nail infections with the addition of pertuzumab to trastuzumab-based chemotherapy.
Mortimer J, Jung J, Yuan Y, Kruper L, Stewart D, Chung S, Yu KW, Mendelsohn M, D'Apuzzo M, Tegtmeier B, Dadwal S. Mortimer J, et al. Among authors: chung s. Breast Cancer Res Treat. 2014 Dec;148(3):563-70. doi: 10.1007/s10549-014-3190-5. Epub 2014 Nov 11. Breast Cancer Res Treat. 2014. PMID: 25385180 Free PMC article. Clinical Trial.
A Phase II Trial of Older Adults With Metastatic Breast Cancer Receiving nab-Paclitaxel: Melding the Fields of Geriatrics and Oncology.
Hurria A, Soto-Perez-de-Celis E, Blanchard S, Burhenn P, Yeon CH, Yuan Y, Li D, Katheria V, Waisman JR, Luu TH, Somlo G, Noonan AM, Lee T, Sudan N, Chung S, Rotter A, Arsenyan A, Levi A, Choi J, Rubalcava A, Morrison R, Mortimer JE. Hurria A, et al. Among authors: chung s. Clin Breast Cancer. 2019 Apr;19(2):89-96. doi: 10.1016/j.clbc.2018.10.002. Epub 2018 Oct 16. Clin Breast Cancer. 2019. PMID: 30503309 Free PMC article. Clinical Trial.
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
Ge X, Yost SE, Lee JS, Frankel PH, Ruel C, Cui Y, Murga M, Tang A, Martinez N, Chung S, Yeon C, Stewart D, Li D, Rajurkar S, Somlo G, Mortimer J, Waisman J, Yuan Y. Ge X, et al. Among authors: chung s. Cancers (Basel). 2022 Sep 1;14(17):4279. doi: 10.3390/cancers14174279. Cancers (Basel). 2022. PMID: 36077811 Free PMC article.
An Analysis and Comparison of Survival and Functional Outcomes in Oropharyngeal Squamous Cell Carcinoma Patients Treated with Concurrent Chemoradiation Therapy within City of Hope Cancer Center Sites.
Pharaon R, Chung S, Amini A, Maghami E, Chowdhury A, Vora N, Chang S, Kang R, Gernon T, Hansen K, Kelly C, Ackerman D, Vora L, Sampath S, Massarelli E. Pharaon R, et al. Among authors: chung s. J Clin Med. 2020 Sep 24;9(10):E3083. doi: 10.3390/jcm9103083. J Clin Med. 2020. PMID: 32987866 Free PMC article.
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.
Borrego-Yaniz G, Ortiz-Fernández L, Madrid-Paredes A, Kerick M, Hernández-Rodríguez J, Mackie SL, Vaglio A, Castañeda S, Solans R, Mestre-Torres J, Khalidi N, Langford CA, Ytterberg S, Beretta L, Govoni M, Emmi G, Cimmino MA, Witte T, Neumann T, Holle J, Schönau V, Pugnet G, Papo T, Haroche J, Mahr A, Mouthon L, Molberg Ø, Diamantopoulos AP, Voskuyl A, Daikeler T, Berger CT, Molloy ES, Blockmans D, van Sleen Y, Iles M, Sorensen L, Luqmani R, Reynolds G, Bukhari M, Bhagat S, Ortego-Centeno N, Brouwer E, Lamprecht P, Klapa S, Salvarani C, Merkel PA, Cid MC, González-Gay MA, Morgan AW, Martin J, Márquez A; Spanish GCA Group; UK GCA Consortium; Vasculitis Clinical Research Consortium. Borrego-Yaniz G, et al. Lancet Rheumatol. 2024 May 8:S2665-9913(24)00064-X. doi: 10.1016/S2665-9913(24)00064-X. Online ahead of print. Lancet Rheumatol. 2024. PMID: 38734017
9,958 results